Urinary neopterin excretion in patients with uterine sarcomas

Neopterin, a pyrazinopyrimidine compound, is a marker of activation of cell‐mediated immunity. Urinary neopterin concentrations were measured in a total of 44 patients with uterine sarcomas. Pretherapeutic neopterin excretions were elevated in 78% (14/18). The mean neopterin concentration of patients with sarcomas was significantly higher (P < 0.0001) than that obtained in women with benign myomas and healthy controls. Furthermore, a significant correlation of normal or raised neopterin concentrations with the clinical course of disease was found. These data suggest that urinary neopterin measurement might be a useful immunologic marker for women with uterine sarcomas.

[1]  P. Comella,et al.  Prognostic relevance of urinary neopterin in non‐Hodgkin's lymphomas , 1989, Cancer.

[2]  W. Mann,et al.  Use of serum CA‐125 in monitoring patients with uterine sarcoma: A preliminary report , 1988, Cancer.

[3]  H. Kawasaki,et al.  Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma. , 1988, The Tohoku journal of experimental medicine.

[4]  A. Berchuck,et al.  Treatment of Uterine Leiomyosarcoma , 1988, Obstetrics and gynecology.

[5]  E. Werner,et al.  Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. , 1988, Immunology today.

[6]  E. Werner,et al.  Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. , 1987, Cancer research.

[7]  H Wachter,et al.  Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. , 1986, Cancer research.

[8]  G. Isshiki,et al.  URINARY NEOPTERIN IN CHILDREN WITH MALIGNANT NEOPLASM , 1985 .

[9]  V. Schneider,et al.  Uterine sarcoma: analysis of prognostic variables in 71 cases. , 1985, American journal of obstetrics and gynecology.

[10]  D. Fuchs,et al.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma , 1984, The Journal of experimental medicine.

[11]  D. Fuchs,et al.  Determination of neopterine in human urine by reversed-phase high-performance liquid chromatography. , 1982, Journal of chromatography.

[12]  E. Werner,et al.  Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. , 1989, Advances in clinical chemistry.

[13]  C. Zaloudek,et al.  Mesenchymal Tumors of the Uterus , 1987 .

[14]  P. Ekman,et al.  Serum levels of neopterin as related to the prognosis of human prostatic carcinoma. , 1986, European Urology.